Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment.
Int J Mol Sci. 2024 Mar 2;25(5):2925. doi: 10.3390/ijms25052925.
Int J Mol Sci. 2024.
PMID: 38474178
Free PMC article.
Review.
Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy.
Pampeno C, Hurtado A, Opp S, Meruelo D.
Pampeno C, et al.
Int J Mol Sci. 2023 Oct 6;24(19):14948. doi: 10.3390/ijms241914948.
Int J Mol Sci. 2023.
PMID: 37834397
Free PMC article.
Review.
Item in Clipboard
Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.
Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG, Thannickal SA, Stapleford KA, Meruelo D.
Scaglione A, et al.
Front Immunol. 2021 Jul 29;12:719077. doi: 10.3389/fimmu.2021.719077. eCollection 2021.
Front Immunol. 2021.
PMID: 34394127
Free PMC article.
Item in Clipboard
Combination of a Sindbis-SARS-CoV-2 spike vaccine and αOX40 antibody elicits protective immunity against SARS-CoV-2 induced disease and potentiates long-term SARS-CoV-2-specific humoral and T-cell immunity.
Scaglione A, Opp S, Hurtado A, Lin Z, Pampeno C, Noval MG, Thannickal SA, Stapleford KA, Meruelo D.
Scaglione A, et al.
bioRxiv [Preprint]. 2021 Jun 2:2021.05.28.446009. doi: 10.1101/2021.05.28.446009.
bioRxiv. 2021.
PMID: 34075383
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors.
Scherwitzl I, Opp S, Hurtado AM, Pampeno C, Loomis C, Kannan K, Yu M, Meruelo D.
Scherwitzl I, et al.
Mol Ther Oncolytics. 2020 May 6;17:431-447. doi: 10.1016/j.omto.2020.04.012. eCollection 2020 Jun 26.
Mol Ther Oncolytics. 2020.
PMID: 32478167
Free PMC article.
Item in Clipboard
Cite
Cite